Related references
Note: Only part of the references are listed.A phase III, intergroup, randomized, double-blind, chemoprevention trial of selenium (Se) supplementation in resected stage I non-small cell lung cancer (NSCLC).
D. D. Karp et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
The Use of Metformin and the Incidence of Lung Cancer in Patients With Type 2 Diabetes
Brielan B. Smiechowski et al.
DIABETES CARE (2013)
Green tea inhibits cycolooxygenase-2 in non-small cell lung cancer cells through the induction of Annexin-1
Qing-Yi Lu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Angiostatic role of the selective cyclooxygenase-2 inhibitor etoricoxib (MK0663) in experimental lung cancer
N. Nadda et al.
BIOMEDICINE & PHARMACOTHERAPY (2012)
The effect of metformin and thiazolidinedione use on lung cancer in diabetics
Peter J. Mazzone et al.
BMC CANCER (2012)
Meta-Analysis on the Association Between Nonsteroidal Anti-Inflammatory Drug Use and Lung Cancer Risk
Jiali Xu et al.
CLINICAL LUNG CANCER (2012)
Pioglitazone Prevents Smoking Carcinogen-Induced Lung Tumor Development in Mice
M. -Y. Li et al.
CURRENT CANCER DRUG TARGETS (2012)
Non-aspirin Non-steroidal Anti-inflammatory Drugs for the Primary Chemoprevention of Non-gastrointestinal Cancer: Summary of Evidence
Marcus Tolentino Silva et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
Thiazolidinedione use and cancer incidence in type 2 diabetes: A systematic review and meta-analysis
I. N. Colmers et al.
DIABETES & METABOLISM (2012)
Multivitamins in the Prevention of Cancer in Men The Physicians' Health Study II Randomized Controlled Trial
J. Michael Gaziano et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials
Peter M. Rothwell et al.
LANCET (2012)
Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials
Peter M. Rothwell et al.
LANCET (2012)
Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials
Annemijn M. Algra et al.
LANCET ONCOLOGY (2012)
Non-steroidal anti-inflammatory drugs and small cell lung cancer risk in the VITAL study
Theodore M. Brasky et al.
LUNG CANCER (2012)
Metformin does not alter the risk of lung cancer: A case-control analysis
Michael Bodmer et al.
LUNG CANCER (2012)
Cancer Risk in Diabetic Patients Treated with Metformin: A Systematic Review and Meta-analysis
Hiroshi Noto et al.
PLOS ONE (2012)
CT Scan Screening for Lung Cancer: Risk Factors for Nodules and Malignancy in a High-Risk Urban Cohort
Alissa K. Greenberg et al.
PLOS ONE (2012)
Green tea catechin, epigallocatechin-3-gallate (EGCG): Mechanisms, perspectives and clinical applications
Brahma N. Singh et al.
BIOCHEMICAL PHARMACOLOGY (2011)
Role of sulforaphane in the anti-initiating mechanism of lung carcinogenesis in vivo by modulating the metabolic activation and detoxification of benzo(a)pyrene
D. Kalpana Deepa Priya et al.
BIOMEDICINE & PHARMACOTHERAPY (2011)
Use of glucosamine and chondroitin and lung cancer risk in the VITamins And Lifestyle (VITAL) cohort
Theodore M. Brasky et al.
CANCER CAUSES & CONTROL (2011)
Indole-3-carbinol inhibited tobacco smoke carcinogen-induced lung adenocarcinoma in A/J mice when administered during the post-initiation or progression phase of lung tumorigenesis
Xuemin Qian et al.
CANCER LETTERS (2011)
Randomized Phase II Trial of Inhaled Budesonide versus Placebo in High-Risk Individuals with CT Screen-Detected Lung Nodules
Giulia Veronesi et al.
CANCER PREVENTION RESEARCH (2011)
Oral Iloprost Improves Endobronchial Dysplasia in Former Smokers
Robert L. Keith et al.
CANCER PREVENTION RESEARCH (2011)
Lung Cancer Chemoprevention with Celecoxib in Former Smokers
Jenny T. Mao et al.
CANCER PREVENTION RESEARCH (2011)
Long-term Use of Cholesterol-Lowering Drugs and Cancer Incidence in a Large United States Cohort
Eric J. Jacobs et al.
CANCER RESEARCH (2011)
Chemoprevention of Lung Carcinogenesis by the Combination of Aerosolized Budesonide and Oral Pioglitazone in A/J Mice
Huijing Fu et al.
MOLECULAR CARCINOGENESIS (2011)
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
Denise R. Aberle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Selenium and Lung Cancer: A Systematic Review and Meta Analysis
Heidi Fritz et al.
PLOS ONE (2011)
Cruciferous vegetable intake is inversely associated with lung cancer risk among smokers: a case-control study
Li Tang et al.
BMC CANCER (2010)
Cruciferous Vegetable Intake and Lung Cancer Risk: A Nested Case-Control Study Matched on Cigarette Smoking
Tram Kim Lam et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
Biological Activity of Celecoxib in the Bronchial Epithelium of Current and Former Smokers
Edward S. Kim et al.
CANCER PREVENTION RESEARCH (2010)
Metformin and Cancer Risk in Diabetic Patients: A Systematic Review and Meta-analysis
Andrea DeCensi et al.
CANCER PREVENTION RESEARCH (2010)
Inhibition of lung carcinogenesis and critical cancer-related signaling pathways by N-acetyl-S-(N-2-phenethylthiocarbamoyl)-l-cysteine, indole-3-carbinol and myo-inositol, alone and in combination
Fekadu Kassie et al.
CARCINOGENESIS (2010)
The Role of the Akt/mTOR Pathway in Tobacco Carcinogen-Induced Lung Tumorigenesis
Regan M. Memmott et al.
CLINICAL CANCER RESEARCH (2010)
Budesonide versus placebo in high-risk population with screen-detected lung nodules: Rationale, design and methodology
Matteo Lazzeroni et al.
CONTEMPORARY CLINICAL TRIALS (2010)
Effect of aspirin and NSAIDs on risk and survival from colorectal cancer
Farhat V. N. Din et al.
GUT (2010)
Incidence of cancer and statin usage-record linkage study
Jari Haukka et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Chemopreventive Effects of Pioglitazone on Chemically Induced Lung Carcinogenesis in Mice
Yian Wang et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Airway PI3K Pathway Activation Is an Early and Reversible Event in Lung Cancer Development
Adam M. Gustafson et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Cruciferous Vegetable Consumption and Lung Cancer Risk: A Systematic Review
Tram Kim Lam et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
Associaton of Nonsteroidal Anti-Inflammatory Drugs with Lung Cancer: Results from a Large Cohort Study
Christopher G. Slatore et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
The Chemopreventive Agent Myoinositol Inhibits Akt and Extracellular Signal-Regulated Kinase in Bronchial Lesions from Heavy Smokers
Wei Han et al.
CANCER PREVENTION RESEARCH (2009)
Effect of Selenium and Vitamin E on Risk of Prostate Cancer and Other Cancers The Selenium and Vitamin E Cancer Prevention Trial ( SELECT)
Scott M. Lippman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Green tea, black tea consumption and risk of lung cancer: A meta-analysis
Naping Tang et al.
LUNG CANCER (2009)
Chemopreventive Effect of Nonsteroidal Anti-inflammatory Drugs on 9,10-Dimethylbenz[a]anthracene-Induced Lung Carcinogenesis in Mice
R. K. Saini et al.
ONCOLOGY RESEARCH (2009)
Association of radiographic emphysema and airflow obstruction with lung cancer
David O. Wilson et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Beta-carotene in multivitamins and the possible risk of lung cancer among smokers versus former smokers - A meta-analysis and evaluation of national brands
Tawee Tanvetyanon et al.
CANCER (2008)
Combinations of N-Acetyl-S-(N-2-Phenethylthiocarbamoyl)-L-Cysteine and myo-Inositol Inhibit Tobacco Carcinogen-Induced Lung Adenocarcinoma in Mice
Fekadu Kassie et al.
CANCER PREVENTION RESEARCH (2008)
Synergistic inhibition of lung tumorigenesis by a combination of green tea polyphenols and atorvastatin
Gang Lu et al.
CLINICAL CANCER RESEARCH (2008)
A phase I study with exploratory pharmacodynamic endpoints of XL647, a novel spectrum selective kinase inhibitor, administered orally daily to patients (pts) with advanced solid malignancies
H. A. Wakelee et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Pioglitazone and rosiglitazone decrease prostaglandin E2 in non-small-cell lung cancer cells by up-regulating 15-hydroxyprostaglandin dehydrogenase
Saswati Hazra et al.
MOLECULAR PHARMACOLOGY (2007)
Statins reduce the risk of lung cancer in humans* - A large case-control study of US veterans
Vikas Khurana et al.
CHEST (2007)
Thiazolidinediones and the risk of lung, prostate, and colon cancer in patients with diabetes
Rangaswamy Govindarajan et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Inhaled corticosteroids and risk of lung cancer among patients with chronic obstructive pulmonary disease
Tanyalak Parimon et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
Lung cancer incidence in never smokers
Heather A. Wakelee et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Nonsteroidal anti-inflammatory drugs and lung cancer risk: A population-based case control study
Richard J. Wall et al.
JOURNAL OF THORACIC ONCOLOGY (2007)
A phase I study of myo-inositol for lung cancer chernoprevention
Stephen Lam et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
Effect of glutathione-S-transferase polymorphisms on the cancer preventive potential of isothiocyanates:: An epidemiological perspective
A Seow et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2005)
Trends in the leading causes of death in the United States, 1970-2002
A Jemal et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Low-dose aspirin in the primary prevention of cancer the women's health study: A randomized controlled trial
NR Cook et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Peroxisome proliferator-activated receptor-γ (PPARγ) inhibits tumorigenesis by reversing the undifferentiated phenotype of metastatic non-small-cell lung cancer cells (NSCLC)
Y Bren-Mattison et al.
ONCOGENE (2005)
The effects of a smoking cessation intervention on 14.5-year mortality - A randomized clinical trial
NR Anthonisen et al.
ANNALS OF INTERNAL MEDICINE (2005)
Tobacco carcinogen-induced cellular transformation increases activation of the phosphatidylinositol 3′-Kinase/Akt pathway in vitro and in vivo
KA West et al.
CANCER RESEARCH (2004)
A randomized phase IIb trial of Pulmicort turbuhaler (budesonide) in people with dysplasia of the bronchial epithelium
S Lam et al.
CLINICAL CANCER RESEARCH (2004)
Effect of increased tea consumption on oxidative DNA damage among smokers: A randomized controlled study
IA Hakim et al.
JOURNAL OF NUTRITION (2003)
Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells
KA West et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Screening for lung cancer - The guidelines
PB Bach et al.
CHEST (2003)
Peroxisome proliferator-activated receptor-γ is a target of nonsteroidal anti-inflammatory drugs mediating cyclooxygenase-independent inhibition of lung cancer cell growth
M Wick et al.
MOLECULAR PHARMACOLOGY (2002)
Glucocorticoids inhibit lung cancer cell growth through both the extracellular signal-related kinase pathway and cell cycle regulators
AK Greenberg et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2002)
Radioprotectants: Current status and new directions
DJ Grdina et al.
ONCOLOGY (2002)
Randomized phase III intergroup trial of isotretinoin to prevent second primary tumors in stage I non-small-cell lung cancer
SM Lippman et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
EUROSCAN, a randomized trial of vitamin A and N-acetylcysteine in patients with head and neck cancer or lung cancer
N van Zandwijk et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Share Paper
